These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3932153)

  • 21. [Myleran treatment in polycythemia vera].
    Yde H
    Nord Med; 1971 Aug; 85(32):968. PubMed ID: 5568439
    [No Abstract]   [Full Text] [Related]  

  • 22. [30 cases of myeloid metaplasia and 5 cases of acute leukemia in a group of 200 cases of polycythemia vera].
    Nicoară S; Butoianu E; Ciocoiu A; Coliţă A; Grigoriu G; Vîlcu A; Ursea C; Dosius L; Niculescu R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):261-6. PubMed ID: 6140721
    [No Abstract]   [Full Text] [Related]  

  • 23. [Polycythemia vera: therapeutic use of busulfan. Comparison with radioactive phosphorous].
    Jamra M; Verrastro T
    Rev Hosp Clin Fac Med Sao Paulo; 1967; 22():Suppl:241-66. PubMed ID: 5629089
    [No Abstract]   [Full Text] [Related]  

  • 24. [Development of polycythemia vera during chronic idiopathic myelofibrosis].
    Paladini G; Tosato F; Mazzanti G; Covaz E
    Minerva Med; 1985 Dec; 76(49-50):2315-7. PubMed ID: 4088526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis.
    Dingli D; Schwager SM; Mesa RA; Li CY; Dewald GW; Tefferi A
    Cancer; 2006 May; 106(9):1985-9. PubMed ID: 16568439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A t(11;14)(p13;q11.2) in myelofibrosis following polycythemia vera.
    Jeong JH; Ahn JY; Park PW; Seo YH; Seo JY; Lee JH; Kim KH
    Cancer Genet; 2016 Mar; 209(3):112-6. PubMed ID: 26826764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of polycythemia vera treated with myleran].
    Migdal A
    Wiad Lek; 1966 May; 19(9):737-9. PubMed ID: 5963614
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of polycythemia vera with busulfan (myleran). Report on results in 40 patients].
    Urasiński I; Mysik M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(4):360-6. PubMed ID: 4101127
    [No Abstract]   [Full Text] [Related]  

  • 29. [Case of polycythemia vera remitting with administration of Myleran].
    Kajiwara N; Kobayashi Y; Kanmatsuse K; Koshino M; Sato M
    Naika; 1969 Oct; 24(4):755-8. PubMed ID: 5358684
    [No Abstract]   [Full Text] [Related]  

  • 30. Concomitant myelofibrosis with agnogenic myeloid metaplasia and malignant lymphoma.
    Jennings WH; Li CY; Kiely JM
    Mayo Clin Proc; 1983 Sep; 58(9):617-9. PubMed ID: 6887976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis.
    Larsen TS; Hasselbalch HC; Pallisgaard N; Kerndrup GB
    Cancer Genet Cytogenet; 2007 Jan; 172(2):107-12. PubMed ID: 17213018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agnogenic myeloid metaplasia. Natural history and treatment.
    Silverstein MN; Gomes MR; ReMine WH; Elveback LR
    Arch Intern Med; 1967 Nov; 120(5):546-50. PubMed ID: 6054588
    [No Abstract]   [Full Text] [Related]  

  • 34. Karyotype and molecular cytogenetic studies in polycythemia vera.
    Andrieux JL; Demory JL
    Curr Hematol Rep; 2005 May; 4(3):224-9. PubMed ID: 15865876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of Polycythemia vera and thrombocythemia with myleran (busulphan).
    Epstein IS
    Isr J Med Sci; 1965 Jul; 1(4):797-9. PubMed ID: 5892718
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic granulocytic leukaemia.
    Baikie AG
    Med J Aust; 1974 Jul; 2(1):12-7. PubMed ID: 4528473
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of JAK2V617F in patients with polycythemia is highly correlated with conventional criteria for diagnosis of polycythemia vera.
    Ganly P; Hanrahan V; Baker B; Romeril K
    Am J Hematol; 2007 Jan; 82(1):80-2. PubMed ID: 16924638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinopathy secondary to anemia from myeloid metaplasia in polycythemia vera.
    Blood AM; Lowenthal EA; Nowakowski RW
    J Am Optom Assoc; 1997 Nov; 68(11):734-8. PubMed ID: 9409109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Unusual case of chronic myeloproliferative syndrome].
    Tosato F; Fossaluzza V
    Arch Sci Med (Torino); 1982; 139(4):531-5. PubMed ID: 6891999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Busulfan versus 32P in polycythaemia vera.
    Zittoun R
    Drugs Exp Clin Res; 1986; 12(1-3):283-5. PubMed ID: 3525077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.